Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Retinal test for Alzheimer's disease: Pilot trial ongoing

NeuroVision said its retinal imaging test will be evaluated to diagnose early AD in individuals enrolled

Read the full 161 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE